PMCPA Case Library

Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.

1,930
Cases
291
Companies
154
Clauses
6
Code Versions

or browse all 154 ABPI clause guides ↗

Case Library Membership

Filter by Company & ABPI Clause

Search free — but unlock advanced filters to find every case involving a specific company or clause.

Filter 1,930+ cases by any of 291 companies
Filter by any of 154 ABPI Code clauses
Filter by Code version (2016, 2019, 2021…)
Full-text keyword search across all cases
Cancel any time

Already a member? Sign in →

Case Library Membership

Best value
£249 /year Save £99

inc. VAT

£29 /month

inc. VAT · cancel any time

Unlock Full Access →

Secure payment via Stripe


Need access for your team?

Company licences available for compliance teams, medical affairs, and training programmes.

Get a team quote →

1,930 cases found

2008
CASE
2008 Code AstraZeneca Clause 9.5

AstraZeneca Zoladex journal advertisement: prohibited reference to the MHRA

The MHRA complained that a Zoladex journal advertisement referenced the MHRA. The Panel ruled this breached Clause 9.5 because such references are…

2008
CASE
2008 Code AstraZeneca Clause 9

AstraZeneca voluntary admission: uncertified promotional email for Crestor with misleading claims

AstraZeneca self-reported an uncertified promotional email about Crestor sent to a dispensing practice. The email and attached slides lacked prescribing information and…

2008
CASE
2008 Code ProStrakan Clause 3

ProStrakan breach for ‘rapid relief from 10 minutes’ claim for Abstral

Cephalon challenged ProStrakan leavepieces claiming Abstral provided rapid relief from 10 minutes. The Panel found the claim inconsistent with the Abstral SPC,…

2009
CASE
2008 Code Gilead Sciences

AUTH/2208/2/09: Health professional v Gilead Sciences – unsolicited email about fellowship programme (no breach)

A health professional complained about an unsolicited email advertising a Gilead fellowship programme. The Panel found the email was non-promotional and ruled…

2009
CASE
2008 Code AstraZeneca

AUTH/2210/3/09: Anonymous v AstraZeneca (conduct of representative) – no breach

Anonymous GP alleged a representative’s hospitality, venue ownership and side businesses created conflicts/inducement concerns. AstraZeneca investigated meetings and payments. Panel raised perception…

2008
CASE
2008 Code Boehringer Ingelheim

Boehringer Ingelheim: Micardis/Micardis Plus journal ad implied unproven long-term cardiovascular benefit

A GP challenged a Prescriber journal ad for Micardis/Micardis Plus. The Panel found the headline implied long-term cardiovascular benefit inconsistent with the…

2008
CASE
2008 Code Boehringer Ingelheim Eli Lilly Clause 2 Clause 12.1

Anonymous doctor v Lilly and Boehringer Ingelheim: sponsored journal supplement found to be disguised promotion

A journal-lookalike supplement reporting a company-run symposium was presented as a sponsored independent forum report. The Panel ruled it was disguised promotion,…

2008
CASE
2008 Code ProStrakan Clause 3

ProStrakan breach for ‘rapid relief from 10 minutes’ claim for Abstral

Cephalon challenged ProStrakan’s claim that Abstral provided rapid relief from 10 minutes. The Panel found the claim inconsistent with the Abstral SPC,…

2009
CASE
2008 Code Gilead Sciences

AUTH/2208/2/09: Health professional v Gilead Sciences – unsolicited email about fellowship programme (no breach)

A health professional received an unsolicited email about Gilead’s UK and Ireland Fellowship Programme and queried how his private address was obtained…

2009
CASE
2008 Code AstraZeneca

AUTH/2210/3/09: Anonymous complaint about AstraZeneca representative’s business interests and hospitality – no breach

Anonymous GP alleged a representative’s venue ownership, free drinks and sports team sponsorship created conflicts and inducement. Panel found concerns about perception…

2008
CASE
2008 Code Boehringer Ingelheim

Micardis/Micardis Plus journal advertisement: implied long-term cardiovascular benefit

A GP challenged a Prescriber journal ad for Micardis and Micardis Plus. The Panel ruled the headline implied unproven long-term cardiovascular benefits,…

2009
CASE
2008 Code Boehringer Ingelheim Eli Lilly Clause 2 Clause 12.1

Lilly and Boehringer Ingelheim: journal insert presented as sponsored supplement found to be disguised promotion (AUTH/2213/3/09, AUTH/2214/3/09)

A journal-lookalike insert reporting a “UK Psychiatry Forum” was ruled disguised promotion because it was output from a company-run promotional symposium and…

2008
CASE
2008 Code Goldshield Clause 9

Goldshield: unsolicited promotional email sent via agency to GP’s NHS address (MacroBid)

A GP received an unsolicited promotional email about MacroBid via an agency. The Panel and Appeal Board found no evidence of prior,…

2008
CASE
2008 Code GlaxoSmithKline

AUTH/2115/4/08 Roche v GlaxoSmithKline: Press releases for Tykerb/Tyverb (lapatinib) on corporate website

Roche challenged two GSK corporate press releases about lapatinib (Tykerb/Tyverb). The Panel ruled one release misleading on adverse events (risk–benefit not fairly…

2008
CASE
2008 Code Sandoz

AUTH/2123/5/08: General practitioner v Sandoz Ltd – promotional email sent via agency (no breach)

A GP complained about large promotional emails sent on Sandoz’s behalf. The Panel found the email was promotional but could not determine…

1118119120121122123124129

Ask questions about any PMCPA case

Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free